Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Bioavailability Study of NALDEBAIN ER Injection and Nalbuphine Injection in Healthy Volunteers.

NCT04256434 is registered in ClinicalTrials.gov with Lumosa Therapeutics Co., Ltd. as lead sponsor.

NCT NCT04256434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04256434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Bioavailability Study of NALDEBAIN ER Injection and Nalbuphine Injection in Healthy Volunteers.
Lead sponsor
Lumosa Therapeutics Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2020
Completion date
May 29, 2020
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

health